Terms ending in 2035
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,333,204 | Solid Antiviral Dosage Forms In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,744,170 | Solid Antiviral Dosage Forms In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,105,365 | Solid Antiviral Dosage Forms In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,118,958 | Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 12,098,189 | Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,777,020 | FURO-3-Carboxamide Derivatives and Methods of Use In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,464,082 | Aryl and Arylalkyl Substituted Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators In force · High confidence | Reata Pharmaceuticals, Inc. | In force | High confidence | |
| US 9,382,247 | Novel Salts and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders In force · High confidence | Alfasigma S.P.A. | In force | High confidence | |
| US 9,452,986 | 6-Heteroaryloxy- or 6-Aryloxy-QUINOLINE-2-Carboxamides and Method of Use In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,493,158 | Pharmaceutical Compositions for the Treatment of Inflammatory Disorders In force · High confidence | Alfasigma S.P.A. | In force | High confidence | |
| 41 more term ends in 2035 · Pro | |||||
10 of 51 patents shown. Soonest term end first, then patent number.
Pro members see all 51.
44 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.